Johnson & Johnson, Roche, and more Major Pharma Companies with their Current Stock Price Movements
Ever since the mid of 2020, pharmaceutical companies had gained a tremendous amount of growth in their stock prices. This was mainly due to the pandemic as the majority of the pharmaceutical and biotech companies were experimenting to find a fix for COVID-19.
This led to a huge shift of investors’ interest from other major stocks to pharma stocks. Eventually, the market valuation and demand for such companies rose tremendously. This also helped increase the market capitalization of major companies on a really large scale.
However, with time, such companies have started losing their stock prices. This is mainly due to the global eradication of the pandemic. As things have started settling down surrounding the pandemic, investors have started losing their interest in the stock performances of such companies.
On the list, the largest publicly-listed pharma company in the world is Johnson & Johnson with a market capitalization of $419.10 billion. The company has experienced a 0.65% dip in its stock prices in today’s stock market, dragging its price down to $159.20 per share. Johnson & Johnson is a pharma company based in the United States.
The second-largest publicly-listed pharma company in the world is Roche with a market capitalization of $335.79 billion. The company has experienced a 0.17% increase in its stock prices in today’s stock market, pushing its price up to $48.41 per share. Roche is a pharma company based in Switzerland.
The third-largest publicly-listed pharma company in the world is Pfizer with a market capitalization of $303.09 billion. The company has experienced a 6.11% increase in its stock prices in today’s stock market, surging its price up to $54.00 per share. Pfizer is a pharma company based in the United States.
The fourth-largest publicly-listed pharma company in the world is Eli Lilly with a market capitalization of $249.06 billion. The company has experienced a 0.62% dip in its stock prices in today’s stock market, dragging its price down to $260.37 per share. Eli Lilly is a pharma company based in the United States.
The fifth-largest publicly-listed pharma company in the world is Novo Nordisk with a market capitalization of $246.74 billion. The company has experienced a 0.80% dip in its stock prices in today’s stock market, dragging its price down to $108.17 per share. Novo Nordisk is a pharma company based in Denmark.
The sixth-largest publicly-listed pharma company in the world is AbbVie with a market capitalization of $205.97 billion. The company has experienced a 1.81% dip in its stock prices in today’s stock market, dragging its price down to $116.51 per share. AbbVie is a pharma company based in the United State.
The seventh-largest publicly-listed pharma company in the world is Merck with a market capitalization of $199.95 billion. The company has experienced a 3.79% dip in its stock prices in today’s stock market, dragging its price down to $79.16 per share. Merck is a pharma company based in the United State.